
|Articles|December 1, 2012
Dabigatran results similar to warfarin in diabetes with NVAF
Patients with nonvalvular atrial fibrillation (NAVF) who also have diabetes experienced similar safety and efficacy with dabigatran relative to warfarin, in comparison without diabetes who have NVAF.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
2
CMS Announces 15 New High-Cost Drugs for Medicare Price Negotiation Program
3
Q&A: Pharmacists Combat Vaccine Fatigue by Personalizing Recommendations for Older Adults
4
AAP Releases Updated Childhood Vaccine Schedule Amid Recent HHS Overhaul
5


















